Molecule Details
| InChIKey | SPWZXWDPAWDKQE-UHFFFAOYSA-N |
|---|---|
| Compound Name | Naluzotan |
| Canonical SMILES | CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.15 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB05562 |
|---|---|
| Drug Name | Naluzotan |
| CAS Number | 740873-06-7 |
| Groups | investigational |
| ATC Codes | nan |
| Description | nan |
Categories: Agents that produce hypertension Amides Antidepressive Agents Central Nervous System Depressants Neurotransmitter Agents Serotonin 5-HT1 Receptor Agonists Serotonin Agents Serotonin Receptor Agonists Sulfones Sulfur Compounds
Cross-references: BindingDB: 50187377 CHEMBL209821 ChemSpider: 9605731 Wikipedia: Naluzotan ZINC: ZINC000003963096
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08908 | HTR1A | 5-hydroxytryptamine receptor 1A | agonist | targets |